Glutathione Reduces Cardiovascular Disease Risk
Researchers have found an enzyme called glutathione peroxidase (GPx3) can significantly lower the risk of heart disease. (Published by PLoS One journals)
We discuss on our previous article that glutathione is an skin whitening agent. Today we discuss about it’s another benefit.
In collaboration with the School of Public Health, discovered that the GPx3 enzyme could potentially be a significant benefit for patients with low levels of good cholesterol (HDL)- Researchers from the University of Minnesota Medical School. However, the enzyme does not make a considerable difference in patients with high levels of HDL.
Glutathione (Gpx3) is a natural antioxidant that helps the body naturally repair itself and helps protect organisms from oxidant injury.
Jordan L. Holtzman, M.D., Ph.D., professor of pharmacology and medicine within the University of Minnesota Medical School, explained:
In our study, we found that people with high levels of the GPx3 enzyme and low levels of good cholesterol were six times less likely to develop cardiovascular disease than people with low levels of both. This GPx3 enzyme gives us a good reason to believe that natural antioxidants like GPx3 are good for heart health.
As Glutathione is associated to heart disease, it could help determine cardiovascular risk in individuals with low HDL and low levels of Glutathione, furthermore.
In the United States 1 in 4 adults are affected by low HDL and low GPx3. This condition can lead to fatal heart attacks and strokes. Researchers are continuously seeking new ways to better identify individuals at risk for these diseases and how patients diagnosed with these diseases can reduce its impact.
It’s important to point out that people should not rush out to their doctors and demand testing for the GPx3 enzyme. But in time, we hope that measuring this enzyme will be a common blood test when determining whether a patient is at risk for cardiovascular disease, including heart attacks and strokes.
The Hisayama study
Glutathione (GSH) appears to have marked antioxidant activities and therefore may prevent cardiovascular disease (CVD). However, there are very few reports on this subject. In a community-based case-control study, we tested the hypothesis that low levels of plasma GSH are closely associated with CVD and its clinical types.